Impact of active ingredients on the swelling properties of orally disintegrating tablets prepared by microwave treatment.
The impact of different active pharmaceutical ingredients (APIs) loading on the properties of orally disintegrating tablets (ODTs) prepared according to our previously reported microwave (MW) treatment process was evaluated using famotidine (FAM), acetaminophen (AAP), and ibuprofen (IBU). None of the APIs interrupted the tablet swelling during the MW treatment and the tablet hardness were improved by more than 20 N. MW treatment, however, led to a significant increase in the disintegration time of the ODTs containing IBU, but it had no impact on that of the ODTs containing FAM or AAP. This increased disintegration time of the ODTs containing IBU was attributed to the relatively low melting point of IBU (Tm=76 °C), with the IBU particles melting during the MW treatment to form agglomerates, which interrupted the penetration of water into the tablets and delayed their disintegration. The effects of the MW treatment on the chemical stability and dissolution properties of ODTs were also evaluated. The results revealed that MW treatment did not promote the degradations of FAM and AAP or delay their release from the ODTs, while dissolution of the ODTs containing IBU delayed by MW treatment. Based on these results, the MW method would be applicable to the preparation of ODTs containing APIs with melting points higher than 110 °C.
Pharmaceutical Science and Technologies, Eisai Co., Ltd., 1 Kawashimatakehaya-machi, Kakamigahara, Gifu 501-6195, Japan.
Syusuke
S
Sano
Department of Pharmaceutical Engineering, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.
Yasunori
Y
Iwao
Pharmaceutical Science and Technologies, Eisai Co., Ltd., 1 Kawashimatakehaya-machi, Kakamigahara, Gifu 501-6195, Japan.
Susumu
S
Kimura
Department of Pharmaceutical Engineering, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.
Shuji
S
Noguchi
Department of Pharmaceutical Engineering, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan. Electronic address: s-itai@u-shizuoka-ken.ac.jp.
Shigeru
S
Itai
D000082:Acetaminophen / Q000008:administration & dosage / Q000737:chemistry*; D000284:Administration, Oral; D004355:Drug Stability; D015738:Famotidine / Q000008:administration & dosage / Q000737:chemistry*; D006244:Hardness; D007052:Ibuprofen / Q000008:administration & dosage / Q000737:chemistry*; D007700:Kinetics; D008872:Microwaves; D012995:Solubility; D013607:Tablets; D013678:Technology, Pharmaceutical / Q000379:methods*; D044366:Transition Temperature; D014867:Water / Q000737:chemistry
D013607:Tablets; D014867:Water; D000082:Acetaminophen; D015738:Famotidine; D007052:Ibuprofen
Acetaminophen; Famotidine; Fluorescence; Ibuprofen; Microwave; Orally disintegrating tablet